Julie Rowe

Appearances

MONITORING SYSTEMIC SOLUBLE CD40L LEVELS POST EUS-RFA IN PATIENTS DIAGNOSED WITH UNRESECTABLE PANCREATIC ADENOCARCINOMA
Date
May 21, 2024
INTRODUCTION: Radiofrequency ablation (RFA) is an emerging therapeutic consideration for pancreatic ductal adenocarcinoma (PDAC), as studies show it induces coagulative necrosis and a host adaptive immune response…
Presenter
Nirav Thosani
The University of Texas Health Science Center at Houston John P and Katherine G McGovern Medical School
Speakers
Madhav Desai
University of Minnesota Health
Kazi Haque
Christine Catinis
Mairin Joseph-Talreja
Lincoln Strickland
Nicolette` Mardik
Putao Cen
Julie Rowe
Curtis Wray
Jennifer Bailey-Lundberg